BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34393393)

  • 1. Efficacy of Antenatal Magnesium Sulfate for Neuroprotection in Extreme Prematurity: A Comparative Observational Study.
    Bansal V; Desai A
    J Obstet Gynaecol India; 2022 Aug; 72(Suppl 1):36-47. PubMed ID: 34393393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal magnesium sulfate and the need for mechanical ventilation in the first three days of life.
    Okito O; Aromolaran A; Massa-Buck B; Abdelatif D; Aly H; Mohamed MA
    Pediatr Neonatol; 2023 Nov; 64(6):644-650. PubMed ID: 37280122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
    Magee L; Sawchuck D; Synnes A; von Dadelszen P; ;
    J Obstet Gynaecol Can; 2011 May; 33(5):516-529. PubMed ID: 21639972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants.
    Bachnas MA; Mose JC; Effendi JS; Andonotopo W
    J Perinat Med; 2014 Jan; 42(1):129-34. PubMed ID: 24062546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antenatal Magnesium Sulfate for Preterm Neuroprotection: A Single-Center Experience from Kuwait Tertiary NICU.
    Ayed M; Ahmed J; More K; Ayed A; Husain H; AlQurashi A; Alrajaan N
    Biomed Hub; 2022; 7(2):80-87. PubMed ID: 35950015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and Safety of Magnesium Sulfate on Neuroprotection: A Meta-analysis Based on PRISMA Guidelines.
    Zeng X; Xue Y; Tian Q; Sun R; An R
    Medicine (Baltimore); 2016 Jan; 95(1):e2451. PubMed ID: 26735551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of dosing schedule on uptake of neuroprotective magnesium sulfate.
    Cuff RD; Sullivan SA; Chang EY
    J Matern Fetal Neonatal Med; 2020 Mar; 33(6):982-986. PubMed ID: 30122071
    [No Abstract]   [Full Text] [Related]  

  • 8. Antenatal magnesium sulfate for both tocolysis and fetal neuroprotection in premature rupture of the membranes before 32 weeks' gestation.
    Jung EJ; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Shin JB; Jeong DH
    J Matern Fetal Neonatal Med; 2018 Jun; 31(11):1431-1441. PubMed ID: 28391733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of magnesium sulfate (MgSO
    Bachnas MA; Akbar MIA; Dachlan EG; Dekker G
    J Matern Fetal Neonatal Med; 2021 Mar; 34(6):966-978. PubMed ID: 31092073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis.
    Crowther CA; Middleton PF; Voysey M; Askie L; Duley L; Pryde PG; Marret S; Doyle LW;
    PLoS Med; 2017 Oct; 14(10):e1002398. PubMed ID: 28976987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroprotection for preterm infants with antenatal magnesium sulphate].
    Marret S; Ancel PY
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1418-1433. PubMed ID: 28166926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection.
    Basu SK; Chickajajur V; Lopez V; Bhutada A; Pagala M; Rastogi S
    J Perinat Med; 2011 Aug; 40(2):185-9. PubMed ID: 21834608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal magnesium levels are safe after maternal MgSO
    Dehaene I; Van Steenstraeten T; De Coen K; De Buyser S; Decruyenaere J; Smets K; Roelens K
    Eur J Pediatr; 2022 Aug; 181(8):2971-2980. PubMed ID: 35595861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial.
    Wolf HT; Brok J; Henriksen TB; Greisen G; Salvig JD; Pryds O; Hedegaard M; Weber T; Hegaard HK; Pinborg A; Huusom LD;
    BJOG; 2020 Sep; 127(10):1217-1225. PubMed ID: 32237024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
    Kamyar M; Manuck TA; Stoddard GJ; Varner MW; Clark E
    BJOG; 2016 Jun; 123(7):1161-6. PubMed ID: 26036660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal and fetal serum concentrations of magnesium after administration of a 6-g bolus dose of magnesium sulfate (MgSO
    Jonsdotter A; Rocha-Ferreira E; Hagberg H; Carlsson Y
    Acta Obstet Gynecol Scand; 2022 Aug; 101(8):856-861. PubMed ID: 35501953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Antenatal Magnesium Sulfate Exposure on Patent Ductus Arteriosus in Premature Infants.
    Okulu E; Kraja E; Kostekci YE; Seker E; Ozisik MS; Sarısoy D; Aslan B; Çakır MS; Demirtaş F; Ramoğlu MG; Uçar T; Erdeve O; Atasay B; Koc A; Arsan S
    Am J Perinatol; 2024 Feb; ():. PubMed ID: 38320597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)-implementation of a national guideline in Canada.
    De Silva DA; Synnes AR; von Dadelszen P; Lee T; Bone JN; ; Magee LA
    Implement Sci; 2018 Jan; 13(1):8. PubMed ID: 29325592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of antenatal steroids in obstetric subgroups.
    Elimian A; Verma U; Canterino J; Shah J; Visintainer P; Tejani N
    Obstet Gynecol; 1999 Feb; 93(2):174-9. PubMed ID: 9932550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antenatal Magnesium and Cerebral Palsy in Preterm Infants.
    Hirtz DG; Weiner SJ; Bulas D; DiPietro M; Seibert J; Rouse DJ; Mercer BM; Varner MW; Reddy UM; Iams JD; Wapner RJ; Sorokin Y; Thorp JM; Ramin SM; Malone FD; Carpenter MW; O'Sullivan MJ; Peaceman AM; Hankins GD; Dudley D; Caritis SN;
    J Pediatr; 2015 Oct; 167(4):834-839.e3. PubMed ID: 26254839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.